Top Story

Breakthrough device designation issued for RightEye’s Parkinson’s assessment system

December 3, 2019
In the Journals

Satralizumab reduces relapse in some patients with neuromyelitis optica spectrum disorder

December 2, 2019
Satralizumab added to immunosuppressant treatment may reduce relapse in some cases of neuromyelitis optica spectrum disorder. The phase 3, randomized, double-masked…
Grand Rounds at the New England Eye Center

Man experiences recurrent bilateral optic neuritis

Ocular Surgery News U.S. Edition, November 25, 2019
Alison J. Lauter, MD; Laurel N. Vuong, MD
A 71-year-old man was referred by his usual ophthalmologist to the neuro-ophthalmology clinic at Tufts Medical Center for bilateral decreased vision associated with…

FDA accepts biologics license application for satralizumab

October 31, 2019
The FDA has accepted a biologics license application for satralizumab for the treatment of neuromyelitis optica spectrum disorder, Genentech/Roche announced in a press…
More Headlines »

Gauze Retrieval of Probes in Pediatric Nasolacrimal Intubation

Ophthalmic Surgery, Lasers and Imaging Retina, May 2009, Volume 40 Issue 3
The authors describe a novel technique that facilitates retrieval of lacrimal probes from the nasal fossa during…
More »

Ocular Emergencies in Giant Cell Arteritis: Preventing Permanent Vision Loss

This activity is supported by an educational grant from Genentech, Inc.

More »
Meeting News Coverage

VIDEO: What's new in neuro-ophthalmology in 2015?

January 15, 2016
More »